Current reports - Page 4 of 31 - Medicalgorithmics S.A.

01 Oct 55/2022 Conclusion of an investment agreement regarding the acquisition of new shares in the Company for a contribution of approximately PLN 220 million (PLN 44.27 per share). Complete the review of strategic options. Disclosure of delayed confidential information – commencement of negotiations regarding the acquisition of 49.99% of the Company’s share capital.

Posted at 22:30h in by Michał Zapora 0 Comments

0 Likes

...

28 Sep 54/2022 Q Patch technology registration delay – disclosure of delayed confidential information

Posted at 15:36h in by Sylwia Wójtowicz 0 Comments

0 Likes

...

28 Jul 52/2022 Conclusion of a final agreement to transfer 100% shares in Medi-Lynx Cardiac Monitoring LLC and conclusion of Support Agreement between React Health Holdings LLC and the Company

Posted at 23:42h in by Tomasz Kisiel 0 Comments

0 Likes

...

28 Jul 51/2022 System DRAI (DeepRhythmAI) registration by US Food and Drug Administration (FDA)

Posted at 23:21h in by Tomasz Kisiel 0 Comments

0 Likes

...

27 Jul 50/2022 List of shareholders holding at least 5 % of the total number of votes at the Extraordinary General Meeting of Medicalgorithmics S.A. on 27 July 2022.

Posted at 18:14h in by Monika Wnuk 0 Comments

0 Likes

...

27 Jul 49/2022 Resolutions of the Extraordinary General Meeting of Medicalgorithmics S.A. held on 27 July 2022

Posted at 18:06h in by Monika Wnuk 0 Comments

0 Likes

...

15 Jul 47/2022 Conclusion of a preliminary agreement for the sale of 100% of the membership interests in the Issuer’s subsidiary (Medi-Lynx Cardiac Monitoring, LLC)

Posted at 20:26h in by Paula Fijałkowska 0 Comments

0 Likes

...

05 Jul 46/2022 Appointment of Members of the Supervisory Board

Posted at 15:47h in by Paula Fijałkowska 0 Comments

0 Likes

...

01 Jul 45/2022 Correction of the current report 42/2022 regarding the list of shareholders holding at least 5% of votes in the total number of votes at the Ordinary General Meeting of Medicalgorithmics S.A. on June 30, 2022

Posted at 17:03h in by Paula Fijałkowska 0 Comments

0 Likes

...

01 Jul 45/2022 Korekta raportu bieżącego 42/2022 dotyczącego wykazu akcjonariuszy posiadających co najmniej 5 % głosów w ogólnej liczbie głosów na Zwyczajnym Walnym Zgromadzeniu Medicalgorithmics S.A. w dniu 30 czerwca 2022 r.

Posted at 15:50h in by Paula Fijałkowska 0 Comments

0 Likes

...

Medicalgorithmics

Arrhythmia
diagnosis

Foundations

Media

Shares and bonds

Corporate governance

Medicalgorithmics

Arrhythmia
diagnosis

Foundations

Media

Shares and bonds

Corporate governance

28 Sep 54/2022 Q Patch technology registration delay – disclosure of delayed confidential information

28 Jul 52/2022 Conclusion of a final agreement to transfer 100% shares in Medi-Lynx Cardiac Monitoring LLC and conclusion of Support Agreement between React Health Holdings LLC and the Company

28 Jul 51/2022 System DRAI (DeepRhythmAI) registration by US Food and Drug Administration (FDA)

27 Jul 50/2022 List of shareholders holding at least 5 % of the total number of votes at the Extraordinary General Meeting of Medicalgorithmics S.A. on 27 July 2022.

27 Jul 49/2022 Resolutions of the Extraordinary General Meeting of Medicalgorithmics S.A. held on 27 July 2022

15 Jul 47/2022 Conclusion of a preliminary agreement for the sale of 100% of the membership interests in the Issuer’s subsidiary (Medi-Lynx Cardiac Monitoring, LLC)

05 Jul 46/2022 Appointment of Members of the Supervisory Board

01 Jul 45/2022 Correction of the current report 42/2022 regarding the list of shareholders holding at least 5% of votes in the total number of votes at the Ordinary General Meeting of Medicalgorithmics S.A. on June 30, 2022

01 Jul 45/2022 Korekta raportu bieżącego 42/2022 dotyczącego wykazu akcjonariuszy posiadających co najmniej 5 % głosów w ogólnej liczbie głosów na Zwyczajnym Walnym Zgromadzeniu Medicalgorithmics S.A. w dniu 30 czerwca 2022 r.

In shorts

Products

Contact

Medicalgorithmics

Arrhythmiadiagnosis

Foundations

Media

Shares and bonds

Corporate governance

Medicalgorithmics

Arrhythmiadiagnosis

Foundations

Media

Shares and bonds

Corporate governance

28 Sep 54/2022 Q Patch technology registration delay – disclosure of delayed confidential information

28 Jul 52/2022 Conclusion of a final agreement to transfer 100% shares in Medi-Lynx Cardiac Monitoring LLC and conclusion of Support Agreement between React Health Holdings LLC and the Company

28 Jul 51/2022 System DRAI (DeepRhythmAI) registration by US Food and Drug Administration (FDA)

27 Jul 50/2022 List of shareholders holding at least 5 % of the total number of votes at the Extraordinary General Meeting of Medicalgorithmics S.A. on 27 July 2022.

27 Jul 49/2022 Resolutions of the Extraordinary General Meeting of Medicalgorithmics S.A. held on 27 July 2022

15 Jul 47/2022 Conclusion of a preliminary agreement for the sale of 100% of the membership interests in the Issuer’s subsidiary (Medi-Lynx Cardiac Monitoring, LLC)

05 Jul 46/2022 Appointment of Members of the Supervisory Board

01 Jul 45/2022 Correction of the current report 42/2022 regarding the list of shareholders holding at least 5% of votes in the total number of votes at the Ordinary General Meeting of Medicalgorithmics S.A. on June 30, 2022

01 Jul 45/2022 Korekta raportu bieżącego 42/2022 dotyczącego wykazu akcjonariuszy posiadających co najmniej 5 % głosów w ogólnej liczbie głosów na Zwyczajnym Walnym Zgromadzeniu Medicalgorithmics S.A. w dniu 30 czerwca 2022 r.

In shorts

Products

Contact

Arrhythmia
diagnosis

Arrhythmia
diagnosis